High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by The Netherlands Cancer Institute
Sponsor:
Information provided by (Responsible Party):
The Netherlands Cancer Institute
ClinicalTrials.gov Identifier:
NCT01646034
First received: June 14, 2012
Last updated: September 2, 2014
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)